OFEV® (nintedanib) time to face IPF head on A broad range of ILD patient base that can benefit Document ID: PC-ZA-102082 05/05/2022 Author: Boehringer Ingelheim Patient identification RELATED CONTENT PC-ZA-102082 Production date: May 2023
